Literature DB >> 3752388

Cisplatin: evaluation of its ototoxic potential.

M Anniko, A Sobin.   

Abstract

The ototoxic potential of cisplatin was analyzed in an organ culture model exposing the hair cells and other inner ear structures to cisplatin doses from 0.1 to 10 micrograms/ml. Selective hair cell degeneration was obvious at concentrations of 0.1 microgram/ml. Incubation with 1 microgram/ml caused morphologic damage in the supporting cells in both the cochlear and vestibular parts of the labyrinth. Exposure to 10 micrograms/ml during five days caused a total collapse of the membranous labyrinth. The morphologic degeneration pattern at the ultrastructural level is nonspecific, except that nuclear chromatin was either swollen and disintegrated or considerably condensed. Based on inner ear concentrations equivalent to aminoglycoside antibiotics in the range of 0.1 to 10 micrograms/ml, cisplatin is, in the in vitro model used in this study, the most ototoxic drug known. However, because of its single dose administration and long intervals between administration, clinical ototoxicity is less pronounced than that from aminoglycoside antibiotics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3752388     DOI: 10.1016/s0196-0709(86)80050-3

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  23 in total

1.  Inhibition of adenylate-cyclase-coupled G protein complex by ototoxic diuretics and cis-platinum in the inner ear of the guinea pig.

Authors:  T Koch; B Gloddek
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

2.  Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer.

Authors:  Süleyman Yilmaz; Fatih Oktem; Emin Karaman
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-28       Impact factor: 2.503

3.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

4.  Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.

Authors:  Samson Jamesdaniel; Donald Coling; Sneha Hinduja; Dalian Ding; Jun Li; Linda Cassidy; Gail M Seigel; Jun Qu; Richard Salvi
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

5.  Application of a neuroprotective ACTH(4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs.

Authors:  F P Hamers; S F Klis; W H Gispen; G F Smoorenburg
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.

Authors:  Robert N Rainey; Sum-Yan Ng; Juan Llamas; Gijsbertus T J van der Horst; Neil Segil
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

7.  Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity.

Authors:  Samson Jamesdaniel; Dalian Ding; Mohammad Habiby Kermany; Bruce A Davidson; Paul R Knight; Richard Salvi; Donald E Coling
Journal:  J Proteome Res       Date:  2008-06-26       Impact factor: 4.466

8.  The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear.

Authors:  J R García-Berrocal; J Nevado; R Ramírez-Camacho; R Sanz; J A González-García; C Sánchez-Rodríguez; B Cantos; P España; J M Verdaguer; A Trinidad Cabezas
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

Review 9.  Drug-induced ototoxicity. Pathogenesis and prevention.

Authors:  M Y Huang; J Schacht
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 10.  Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models.

Authors:  Celia Casares; Rafael Ramírez-Camacho; Almudena Trinidad; Amaya Roldán; Eduardo Jorge; José Ramón García-Berrocal
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-15       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.